Dr. Paul Grossman

I was totally hooked. There weren’t many people applying chemical engineering to biological problems. It was new and there were opportunities. I could see the power of working at the intersections of different fields.

Paul Grossman, Ph.D., is Life Technologies' Senior Vice President of Strategy and Corporate Development, which is a leading maker of materials, instruments, and analytic systems for use in biotech R&D, biologics manufacturing, and the delivery of biomedical goods and services.

Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company with customers in more than 160 countries using its innovative solutions to solve some of today’s most difficult scientific challenges. Quality and innovation are accessible to every lab with its reliable and easy-to-use solutions spanning the biological spectrum with more than 50,000 products for translational research, molecular medicine and diagnostics, stem cell-based therapies, forensics, food safety and animal health. Its systems, reagents and consumables represent some of the most cited brands in scientific research including: Ion Torrent™, Applied Biosystems®, Invitrogen™, GIBCO®, Ambion, Molecular® Probes, Novex®, and TaqMan®. Life Technologies employs approximately 10,400 people and upholds its ongoing commitment to innovation with more than 4,000 patents and exclusive licenses. LIFE had sales of $3.7 billion in 2011.

Prior to joining Invitrogen, Dr. Grossman held a variety of leadership roles during his more than 20 years at Applied Biosystems, including working as a research scientist, a patent attorney, Vice President of Intellectual Property and Vice President of Strategy and Business Development. In his tenure at Life Technologies and its legacy companies, Dr. Grossman has spearheaded the acquisition of more than 15 companies, including the merger of Invitrogen and Applied Biosystems, and is also is responsible for a corporate development strategy that includes executing on innovative approaches to grow and monetize the company's substantial intellectual property portfolio of 3,900 patents and licenses.

Dr. Grossman’s story is a quintessential biotech tale. It is the story of an individual taking advantage of unusually fluid organizational conditions to fashion a career that would be nigh impossible in a more structured environment. Dr. Grossman has made innovative contributions to technological progress and the commercial success of biotech firms while moving through an unlikely series of career transitions.

Dr. Grossman received B.S. and Ph.D. degrees in chemical engineering from the University of California, Berkeley, a M.S. in chemical engineering from the University of Virginia, and a J.D. from Santa Clara University School of Law. He has authored numerous scientific publications and holds more than 70 U.S. and foreign patents

Podcast:

May 16, 2012

01: Is It Time to Run From The Herd?

Find out why your safest bet might be to run in the opposite direction of the herd. Brian talks about the historic event of our total debt as a nation exceeding our total GDP and how the US gets a "pass" when it comes to risk evaluation by our lenders.

02: Is It Time to Buy Gold?

Brian talks with local gold expert, Mark Lonneker about gold's recent price drop and whether or not it's a buying opportunity or a time for caution.

03: Making Human Genome Mapping Accessible to Everyone

Brian welcomes Paul Grossman of Life Technologies Corporation in Carlsbad California to discuss a new breakthrough in Genome mapping that could change everything about medicine and health care sooner than you might think. Life Technologies has recently built a tabletop gene-sequencing machine that can map the human genome in under 1 day for less than $1000.

04: Making Science Sexy Again

Paul Grossman shares the latest and greatest scientific technologies that his company is developing and talks about how scientists are changing the way we live for the better. Learn how Life Technologies is developing cutting edge approaches to everything from healthcare to food safety to criminal justice!